Abstract
Senile dementia of the Alzheimer’s type (SDAT) is a progressive cerebral neurodegeneration which is known to affect approximately 5% of the population over age 65 in every industrialized country. SDAT patients show correlative changes in various physiological, morphological, biochemical and clinical parameters. In recent years, a number of biochemical studies have attempted to define neurochemical changes which occur during SDAT. The characteristics of a number of neurotransmitter systems have been investigated (Terry and Davies, 1980) and changes in the number of receptors (Reisine et al., 1978), transmitter synthesizing enzyme activities (Perry et al., 1978) and transmitter levels (Richter et al., 1980) have already been demonstrated. Since changes in the cholinergic and some neuropeptide transmitter systems (Rossor et al., 1982; Davies et al., 1982) have been reported in brain tissue of patients with this disorder, we decided to simultaneously characterize biochemical markers for the cholinergic system (choline acetyltransferase (CAT, EC 2.3.1.6), muscarinic acetylcholine receptor (mAChR) and to investigate the possible changes in the somatostatin, delta and mu opiate receptor systems.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blessed, G., Tomlinsons, B. E. and Roth, M.: The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psych., 114, 797–811, (1968).
Bowen, D.M., Spillane, J.A., Curzon, G., Meier-Ruge, W., White, P., Goodhardt, M.J., Iwangoff, P. and Davidson, A.N.: Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet, 1, 11–14, 1979.
Coyle, J.T., Price, D.L. and Delong, M.R.: Alzheimer’s disease: a disorder of cholinergic innervation. Science, 219, 1184–1190, 1983.
Czernik, A.J. and Petrack, B.: Somatostatin receptor binding in rat cerebral cortex. J. Biol. Chem., 258, 5525–5530, 1983.
Davies, P. and Verth, A.H.: Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer’s-type dementia brains. Brain Res, 138, 385–392, 1978.
Davies, P., Katzman, R. and Terry, R.D.: Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature, 288, 279–280, 1980.
Davies, P. and Terry, R.: Cortical somatostatin-like immunoreactivity in cases of Alzheimer’s disease and senile dementia of the Alzheimer type. Neurobiol. of Aging, 2, 9–14, 1981.
Davies, P., Katz, D.A. and Crystal, H.A.: Choline acetyltransferase, somatostatin, and substance P in selected cases of Alzheimer’s disease, Alzheimer’s disease: A report of progress. (Aging, Vol. 19), ed. S. Corkin et al., Raven Press, New York, 1982.
Garvey, J.M., Rossor, M. and Iversen, L.L.: Evidence for multiple muscarinic receptor subtypes in human brain. J. Neurochem. 43, 299–302, 1984.
Kitt, C.A., Price, D.L., Struble, R.G., Cork, L.C., Wainer, B.H., Becher, M.W. and Mobley, W.C.: Evidence for cholinergic neurites in senile plaques. Science, 226, 1443–1445, 1984.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J.: Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265–275, 1951.
Mckinney, M., Davies, P. and Coyle, J.T.: Somatostatin is not co-localized in cholinergic neurons innervating the rat cerebral cortex hippocampal formation. Brain Res, 243, 169–172, 1982.
Messing, R.B., Vasquez, B.J., Spiehler, V.R., Martinez, J.L., Jensen, R.A., Rigter, H. and Mcgaugh, J.L.: 3H-dihydromorphine binding in brain regions of young and aged rats. Life Sci, 26, 921–927, 1980.
Messing, R.B., Vasquez, B.J., Samaniego, B., Jensen, R.A., Martinez, J.L. and MCGAUGH, J.L.: Alterations in dihydromorphine binding in cerebral hemispheres of aged male rats. J. Neurochem. 36, 784–790, 1981.
Nordberg, A., Larsson, C., Adolfsson, R., Alafuzoff, I. and Winblad, B.: Muscarinic receptor compensation in hippocampus of Alzheimer patients. J. Neural. Transmission, 56, 13–19, 1983.
Perry, E.K., Tomlinson, B.E., Blessed, G., Bergman, K., Gibson, P.H. and Perry, R.H.: Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J., 2, 1457–1459, 1978.
Reisine, T.D., Yamamura, H.I., Bird, E.D., Spokes, E. and Enna, S.J.: Pre- and postsynaptic neurochemical alterations in Alzheimer’s disease. Brain Res., 159, 477–481, 1978.
Reisine, TD., Pedigo, NW., Meiners, B., Iqbal, K. and Yamamura, HI. Alzheimer’s disease: studies on neurochemical alterations in the brain. Aging of the Brain and Dementia (Aging, Vol. 13), ed. L. Amaducci et al., Raven Press, New York, 1980.
Richter, J.A., Perry, E. and Tomlinson, B.E.: Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer’s disease. Life Sci, 26, 1683–1689, 1980.
Rossor, M., Fahrenkrug, J., Emson, P., Mountjoy, C., Iversen, L. and Roth, M.: Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer’s type is not accompanied by changes in vasoactive intestinal polypeptide. Brain Res, 201, 249–253, 1980.
Rossor, MN, Emson, PC., Iversen, LL., Mountjoy, CQ., Roth, M., Fahrenkrug, J. and Rehfeld, JF.: Neuropeptides and neurotransmitters in cerebral cortex in Alzheimer’s disease. Alzheimer’s disease: A report of progress. (Aging, Vol. 19), ed. S. Corkin et al., Raven Press, New York, 1982.
Rossor, M.N., Svendsen, C., Hunt, S.P., Mountjoy, C.Q., Roth, M. and Iversen, L.L.: The substantia innominata in Alzheimer’s disease: an histochemical and biochemical study of cholinergic marker enzymes. Neurosci. Lett., 28, 217–222, 1982.
Roth, G.S.: Brain dopaminergic and opiate receptors and responsiveness during aging. Aging Brain and Ergot Alkaloids (Aging, Vol. 23), ed. A. Agnoli et al., Raven Press, New York, 1983.
Terry, R.D. and Davies, P.: Dementia of the Alzheimer type. Ann. Rev. Neurosci., 3, 77–95, 1980.
Vickroy, T.W., Roeske, W.R. and Yamamura, H.I.: Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-3H cismethyldioxolane. J. Pharm. Exp. Ther., 229, 747–755, 1984.
Vincent, S.R., Staines, W.A. and Fibiger, H.C.: Histochemical demonstration of separate populations of somatostatin and cholinergic neurons in the rat striatum. Neurosci. Lett., 35, 111–114, 1983.
Watson, M., Yamahura, H.I. and Roeske, W.R.: A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct and M2 muscarinic receptor subtypes. Life Sci, 32, 3001–3011, 1983.
Yamamura, H.I. and Snyder, S.H.: Muscarinic cholinergic receptor binding in rat brain. Proc. Natl. Acad. Sci., U.S.A., 71, 1725–1729, 1974.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Gulya, K. et al. (1986). Examination of Cholinergic and Neuropeptide Receptor Alterations in Senile Dementia of the Alzheimer’s Type (SDAT). In: Fisher, A., Hanin, I., Lachman, C. (eds) Alzheimer’s and Parkinson’s Disease. Advances in Behavioral Biology, vol 29. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2179-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2179-8_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9283-8
Online ISBN: 978-1-4613-2179-8
eBook Packages: Springer Book Archive